Mustang Bio EV - Enterprise Value 2011-2026 | MBIO

Annual EV - Enterprise Value Mustang Bio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-5.03 M	7.15 M	11.6 M	-20.6 M	-8.96 M	152 M	96.7 M	81.3 M	275 M	-24.3 M	4.13 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
275 M	-24.3 M	51.8 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Verastem VSTM	388 M	$ 5.04	-4.73 %	$ 349 M	USA
Voyager Therapeutics VYGR	232 M	$ 3.96	-4.12 %	$ 232 M	USA
VistaGen Therapeutics VTGN	20.3 M	$ 0.57	-5.87 %	$ 17.6 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	4.02 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	5.65 B	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	2.7 B	$ 12.41	-11.1 %	$ 1.88 B	USA
Wave Life Sciences Ltd. WVE	2.11 B	$ 6.37	2.66 %	$ 1.07 B	Singapore
Xenetic Biosciences XBIO	-2.54 M	$ 2.72	-2.86 %	$ 4.63 M	USA
XBiotech XBIT	-45.4 M	$ 2.27	-1.73 %	$ 69.2 M	USA
Xenon Pharmaceuticals XENE	2.9 B	$ 54.48	-1.89 %	$ 4.24 B	Canada
Xeris Pharmaceuticals XERS	1.23 B	$ 5.4	-3.05 %	$ 866 M	USA
X4 Pharmaceuticals XFOR	66 M	$ 4.04	-6.26 %	$ 171 M	USA
Xencor XNCR	1.08 B	$ 11.42	-7.23 %	$ 848 M	USA
XOMA Corporation XOMA	416 M	$ 30.17	-1.18 %	$ 364 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
22nd Century Group XXII	1.92 M	$ 2.41	-18.03 %	$ 444 K	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Zai Lab Limited ZLAB	21.4 B	$ 18.0	2.8 %	$ 19.7 B	China
Enlivex Therapeutics Ltd. ENLV	122 M	$ 1.05	-3.67 %	$ 21.5 M	Israel
Enochian Biosciences ENOB	145 M	-	-	$ 40.5 M	USA